# Probiotics and Influenza Vaccination Response

> **NCT05690373** · NA · COMPLETED · sponsor: **The Archer-Daniels-Midland Company** · enrollment: 100 (actual)

## Conditions studied

- Vaccine Response

## Interventions

- **DIETARY_SUPPLEMENT:** Probiotic effect on influenza vaccine response

## Key facts

- **NCT ID:** NCT05690373
- **Lead sponsor:** The Archer-Daniels-Midland Company
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-20
- **Primary completion:** 2023-06-30
- **Final completion:** 2023-06-30
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2023-08-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05690373

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05690373, "Probiotics and Influenza Vaccination Response". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05690373. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*